Med-Chemist : "Quintessential Medicinal Chemistry"
Wednesday, October 2, 2019
FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease
›
In continuation of my update on ruxolitinib Incyte Corporation announced that the U.S. Food and Drug Administration (FDA...
Tuesday, October 1, 2019
Ocular Therapeutix Announces FDA Approval of Dextenza (dexamethasone intracanalicular insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery
›
In continuation of my update on Dextenza Ocular Therapeutix™, Inc. ), a biopharmaceutical company focused on the formulation, develop...
Saturday, September 28, 2019
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
›
In continuation of my update on bremelanotide MAG Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administrati...
Friday, September 27, 2019
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression
›
In continuation of my update on Cariprazine Allergan plc (NYSE: AGN) and Gedeon Richter Plc. announced that the U.S. Food and Drug A...
Thursday, September 26, 2019
FDA Approves Zerbaxa (ceftolozane and tazobactam) 3g Dose for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)
›
Ceftolozane/tazobactam Tazobactam ...
Wednesday, September 25, 2019
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression
›
In continuation of my update on VRAYLAR ( cariprazine ) Allergan plc (NYSE: AGN) and Gedeon Richter Plc. announced that the U.S...
Tuesday, September 24, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to Include Patients 2-5 Years of Age
›
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that the U.S. Food and Drug Administration (FDA) approved the company's s...
Tuesday, August 20, 2019
FDA Approves Wakix (pitolisant), a First-in-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy
›
Harmony Biosciences, LLC (Harmony) announced the U.S. Food and Drug Administration (FDA) approval of Wakix (pitolisant) for the treatm...
Thursday, August 15, 2019
FDA Approves Boxed Warning About Increased Risk of Blood Clots and Death with Higher Dose of Tofacitinib (Xeljanz, Xeljanz XR)
›
In continuation of my update on tofacitinib The U.S. Food and Drug Administration has approved new warnings about an increased risk o...
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
›
Imipenem ( Primaxin) Cilastatin Relebactam Merck (NYSE:MRK), known a...
‹
›
Home
View web version